AI assistant
BLUGLASS LIMITED — Share Issue/Capital Change 2026
May 10, 2026
64532_rns_2026-05-10_38c23680-d677-4d75-8201-264b48cfacd8.pdf
Share Issue/Capital Change
Open in viewerOpens in your device viewer
BLUGLASS
BluGlass Limited (ASX:BLG)
ABN 20 116 825 793
74 Asquith Street
Silverwater, NSW 2128
11 May 2026
Notice given under section 708A(5)(e) of Corporations Act 2001 (Cth)
This notice is given by BluGlass Limited (ACN 116 825 793) (BluGlass or the Company) under section 708A(5)(e) of the Corporations Act 2001 (Cth) (Act).
BluGlass has today issued 40,138 new fully paid ordinary shares (Shares) pursuant to the exercise of vested performance rights. The Company has today lodged with ASX an Appendix 2A in respect of these Shares.
BluGlass confirms that:
- the Shares were issued to investors without disclosure under Part 6D.2 of the Act;
- this notice is being given under section 708A(5)(e) of the Act;
- as at the date of this notice, BluGlass has complied with:
(a) the provisions of Chapter 2M of the Act as they apply to BluGlass; and
(b) section 674 and 674A of the Act,
- as at the date of this notice, there is no excluded information of the type referred to in sections 708A(7) and 708A(8) of the Act that is required to be set out in this notice under section 708A(6)(e) of the Act.
Andrew Palfreyman
Company Secretary
This announcement has been approved for release by the Board of BluGlass.
For more information, please contact:
Jasmine Walters, Automatic Markets | +61 498 209 019 | [email protected]
Samuel Samhan, BluGlass CFO | [email protected]
About BluGlass
BluGlass Limited (ASX:BLG) is a leading supplier of GaN laser diode products to the global photonics industry, focused on the industrial, defence, bio-medical, and scientific markets.
Listed on the ASX, BluGlass is one of just a handful of end-to-end GaN laser manufacturers globally. Its operations in Australia and the USA offer cutting-edge, custom laser diode development and manufacturing, from small-batch custom lasers to medium and high-volume off-the-shelf products.
Its proprietary low temperature, low hydrogen, remote plasma chemical vapour deposition (RPCVD) manufacturing technology and novel device architectures are internationally recognised, and provide the potential to create brighter, better performing lasers to power the devices of tomorrow.
Developing the next evolution in GaN technology
Plug-and-play and custom laser diodes
bluglass.com